FDA Works to Reduce the Spread of Misinformation

The U.S. Food and Drug Administration (FDA) recently issues a press release to help address and reduce the spread of misinformation. The FDA has taken steps to update its draft guidance titled, “Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers.”

From the FDA: “Specifically, the revised draft guidance, Addressing Misinformation About Medical Devices and Prescription Drugs Questions and Answers, sets out a policy that supports companies that issue certain kinds of internet-based communications (“tailored responsive communications”) to address internet-based misinformation about or related to their approved/cleared medical products when that misinformation is created or disseminated by an independent third party.”